Personal profile
Research interests
Dr. Hong Zheng's research focus is transplant immunology and developmental therapeutics for leukemia. Her study is dedicated to improve the understanding of the complex immune response involved in leukemia pathogenesis and allogeneic hematopoietic stem cell transplantation, and subsequently develop effective leukemia therapeutics.
Currently, she is involved in developing early-phase clinical studies testing the safety and efficacy of immunotherapy for leukemia. Her laboratory studies involve targeting T-cell inhibitory mechanisms as a strategy to improve anti-leukemia immunity.
Clinical interests
Dr. Hong Zheng cares for patients with hematological malignancies, including leukemia and lymphoma, as well as patients undergoing hematopoietic stem cell transplantation.
Professional information
Board-certified in Hematology and Medical Oncology
Education/Academic qualification
Hematology and Oncology, Fellowship, Yale University
… → 2013
Internal Medicine, Residency, Penn State Health Milton S. Hershey Medical Center
… → 2010
Postdoctoral Fellowship, Yale University
… → 2007
Immunology, PhD, University of Connecticut
… → 2003
Clinical Medicine, MD, Capital Medical University
… → 1995
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
Qian, F., Sarkar, D., Arner, B. E., Peduzzi, V. M., Bai, Y., Ruan, B., Jia, B., Zheng, H., Paulson, R. F. & Prabhu, K. S., Dec 23 2025, In: Blood Advances. 9, 24, p. 6326-6339 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity
Zhao, C., Jia, B., Jiang, Y., Shike, H., Annageldiyev, C., Cioccio, J., Minagawa, K., Mineishi, S., Ehmann, W., Schell, T. D., Cheng, H. & Zheng, H., Mar 2025, In: Cancer Immunology, Immunotherapy. 74, 4, 117.Research output: Contribution to journal › Article › peer-review
Open Access -
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation
Velasco, C. M., Inoue, Y., Cioccio, J., Rakszawski, K., Songdej, N., Nickolich, M., Zheng, H., Naik, S., Ehmann, C., Mierski, J., Silar, B., Vajdic, C., Greiner, R., Brown, V., Mineishi, S., Shike, H. & Minagawa, K., Aug 2025, In: British Journal of Haematology. 207, 2, p. 515-524 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis
Venugopal, N., McGowan, A., Inoue, Y., Zheng, H., Cioccio, J., Rakszawski, K., Songdej, N., Nickolich, M., Naik, S., Ehmann, C., Sivik, J., Mierski, J., Silar, B., Vajdic, C., Shike, H., Mineishi, S. & Minagawa, K., Dec 2025, In: Annals of Hematology. 104, 12, p. 6451-6462 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomimetic Bacterial Capsule for Enhanced Aptamer Display and Cell Recognition
Wang, X., Jia, B., Lee, K., Davis, B., Wen, C., Wang, Y., Zheng, H. & Wang, Y., Jan 10 2024, In: Journal of the American Chemical Society. 146, 1, p. 868-877 10 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Link opens in a new tab Scopus citations